CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
CYNA was delisted on the 20th of October, 2016.
31 hedge funds and large institutions have $85.2M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
3% more funds holding
Funds holding: 30 → 31 (+1)
0% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 7
20% less capital invested
Capital invested by funds: $107M → $85.2M (-$21.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
+$10M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.86M |
| 3 |
NC
Nexthera Capital
New York
|
+$452K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$211K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
-$8.92M |
| 2 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$1.39M |
| 3 |
CC
CQS Cayman
Camana Bay, Grand Cayman,
Cayman Islands
|
-$635K |
| 4 |
JGC
J. Goldman & Co
New York
|
-$458K |
| 5 |
Millennium Management
New York
|
-$326K |
CYNA Hedge Fund Activity: Q1 2016 in Review
31 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q1 2016, worth a combined $85.2M — down 20% from $107M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CYNA positions and 6 closed out — a net gain of 1 holder — while 7 added to existing stakes and 7 trimmed.
The largest buyer was Visium Asset Management, opening a new position worth an estimated $10M. The largest seller was Broadfin Capital, exiting entirely with an estimated $8.92M sold.
- 31 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q1 2016, up from 30 in Q4 2015.
- Funds reported $85.2M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q1 2016, down 20% quarter-over-quarter.
- 7 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q1 2016 and 6 closed out, a net change of +1 holder.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q1 2016 was Visium Asset Management, an estimated $10M added.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q1 2016 was Broadfin Capital, an estimated $8.92M sold.
Based on aggregated 13F filings for Q1 2016.